SCHEMBL5770537

SCHEMBL5770537

COc1ccc2c(c1)C(N1CCNCC1)C(OCc1cc(Br)cc(Br)c1)C2

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.39
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
HTR2A P28223 3/20 0.36
HTR2C P28335 3/20 0.36
HTR2B P41595 3/20 0.36
TACR1 P25103 3/20 0.35
OPRM1 P35372 2/20 0.34
OPRD1 P41143 1/20 0.34
HTR1A P08908 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
MTNR1B P49286 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4132230 1.00 SIGMAR1 (0.39) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5200282 1.00 SIGMAR1 (0.39) SIGMAR1HTR3EHTR3BHTR3AHTR3D
Hydrochloric Acid SCHEMBL4132226 1.00 SIGMAR1 (0.39) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4121207 0.93 SIGMAR1 (0.36) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4121203 0.93 SIGMAR1 (0.36) SIGMAR1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5198931 0.90 SIGMAR1 (0.44) SIGMAR1HTR2AHTR2CHTR2BMTNR1B
SCHEMBL5198934 0.90 SIGMAR1 (0.44) SIGMAR1HTR2AHTR2CHTR2BMTNR1B
Hydrochloric Acid SCHEMBL4121450 0.90 SIGMAR1 (0.44) SIGMAR1HTR2AHTR2CHTR2BMTNR1B
Hydrochloric Acid SCHEMBL4121446 0.90 SIGMAR1 (0.44) SIGMAR1HTR2AHTR2CHTR2BMTNR1B
Hydrochloric Acid SCHEMBL4124549 0.90 SIGMAR1 (0.39) SIGMAR1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1710240-A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists Les Laboratoires Servier (FR) 2006-10-11 EP disclosed